The Experience of Fertility Preservation in a Single Tertiary Center in Korea
- PMID: 35518927
- PMCID: PMC9062070
- DOI: 10.3389/fendo.2022.845051
The Experience of Fertility Preservation in a Single Tertiary Center in Korea
Abstract
Objective: Oocyte (OC), embryo (EC), and ovarian tissue cryopreservation (OTC) are options for fertility preservation (FP) before going through gonadotoxic cancer treatment, or anticipated fertility decline in benign ovarian diseases, or for planned OC. The aim of this study is to report outcomes of FP in a single tertiary hospital in Korea.
Methods: This is a retrospective study of OC, EC, and OTC cycles. All patients who visited or were referred to the infertility clinic at the Department of Obstetrics and Gynecology for the purpose of FP between 2010 and October 2021 were included.
Results: A total of 564 controlled ovarian stimulation cycles were conducted in 416 women. Three hundred fifty-seven women underwent 494 OC cycles. Most patients were diagnosed with breast cancer (22.4%), followed by endometriomas (21.9%), and then by planned OC (20.7%). Cases of OC have increased over the years, peaking at 109 cycles in 2019 compared to one in 2010. Fifty-nine women underwent 70 EC cycles, and breast cancer (50.8%) was the most common indication. Repetitive OC and EC cycles were undergone in 92 and 9 women, respectively (mean number of repetition, 1.37 and 1.19 times in OC and EC, respectively), yielding a maximum number of 33 oocytes or 23 embryos being cryopreserved per patient. The utilization rate was 3.1% (11/357) in OC and 16.9% (10/59) in EC. Twenty-six women underwent OTC, and gynecologic cancer was the most common indication (9/26, 34.6%). One woman had the cryopreserved ovarian tissue retransplanted and successfully generated embryos.
Conclusion: OC, EC, and OTC are possible options for preserving fertility, and these opportunities should be provided for women at risk of fertility decline or those who are eager to protect their future fertility. This is the first report on long-term FP outcomes in a single tertiary center in Korea. We expect that there will be more cases over the years and more women returning to use their gametes or embryos for pregnancy.
Keywords: embryo cyropreservation; fertility preservation; oncofertility; oocyte cryopreservation; ovarian tissue cryopreservation.
Copyright © 2022 Choi, Hong, Kim, Kim, Lee and Suh.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Combining fertility preservation procedures to spread the eggs across different baskets: a feasibility study.Hum Reprod. 2020 Nov 1;35(11):2524-2536. doi: 10.1093/humrep/deaa193. Hum Reprod. 2020. PMID: 32951035
-
Long term pregnancy outcomes of women with cancer following fertility preservation: A systematic review and meta-analysis.Eur J Obstet Gynecol Reprod Biol. 2023 Feb;281:41-48. doi: 10.1016/j.ejogrb.2022.12.016. Epub 2022 Dec 10. Eur J Obstet Gynecol Reprod Biol. 2023. PMID: 36535069
-
Ovarian tissue cryopreservation for fertility preservation in 418 girls and adolescents up to 15 years of age facing highly gonadotoxic treatment. Twenty years of experience at a single center.Acta Obstet Gynecol Scand. 2019 May;98(5):630-637. doi: 10.1111/aogs.13616. Epub 2019 Apr 14. Acta Obstet Gynecol Scand. 2019. PMID: 30919447
-
Oocyte cryopreservation review: outcomes of medical oocyte cryopreservation and planned oocyte cryopreservation.Reprod Biol Endocrinol. 2022 Jan 7;20(1):10. doi: 10.1186/s12958-021-00884-0. Reprod Biol Endocrinol. 2022. PMID: 34996479 Free PMC article. Review.
-
Oocyte cryopreservation versus ovarian tissue cryopreservation for adult female oncofertility patients: a cost-effectiveness study.J Assist Reprod Genet. 2021 Sep;38(9):2435-2443. doi: 10.1007/s10815-021-02222-0. Epub 2021 May 11. J Assist Reprod Genet. 2021. PMID: 33977465 Free PMC article.
Cited by
-
A comprehensive review and update on human fertility cryopreservation methods and tools.Front Vet Sci. 2023 Apr 18;10:1151254. doi: 10.3389/fvets.2023.1151254. eCollection 2023. Front Vet Sci. 2023. PMID: 37143497 Free PMC article. Review.
-
Outcomes of Fertility Preservation for Female Cancer Patients in a Single Tertiary Center.Yonsei Med J. 2023 Aug;64(8):497-504. doi: 10.3349/ymj.2023.0009. Yonsei Med J. 2023. PMID: 37488701 Free PMC article.
References
-
- Seo SH. Low Fertility Trend in the Republic of Korea and the Problems of its Family and Demographic Policy Implementation. Population Economics (2019) 3(2):29–35. doi: 10.3897/popecon.3.e37938 - DOI
MeSH terms
LinkOut - more resources
Full Text Sources
Medical